Improving Pancreatic Cancer Care by the Use of Computational Science and Technology
Launched by UMC UTRECHT · Sep 22, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The IMPACT project is a clinical trial aimed at improving the care of patients with pancreatic cancer and related conditions. The main goal is to create a system that allows different medical centers to share important patient data. By doing this, researchers can develop and test new computer tools that could help doctors provide better treatment and care for patients diagnosed with pancreatic cancer.
To participate in this trial, you must be at least 18 years old and either have been diagnosed with pancreatic issues (whether benign or malignant) or be a healthy individual who has had an abdominal CT scan. If you choose to join, your data will contribute to important research that could enhance the quality of care for future patients. However, if you prefer not to have your data used for research, you won’t be able to participate. This study is currently looking for new participants, and both men and women are welcome to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years of age
- • Patients who received diagnostic procedures and/or treatment for (suspected) benign and malignant pancreatic lesions as registered in the Dutch Pancreatic Cancer Project (PACAP) audit database and healthy individuals who received an abdominal CT-scan (controls)
- Exclusion Criteria:
- • - Subjects who object to the use of their data for the purpose of scientific research
About Umc Utrecht
UMC Utrecht is a leading academic medical center in the Netherlands, renowned for its commitment to innovative research and high-quality patient care. As a prominent sponsor of clinical trials, UMC Utrecht leverages its extensive expertise in translational medicine and collaboration with various stakeholders to advance medical knowledge and improve therapeutic outcomes. The institution emphasizes ethical conduct and rigorous scientific standards, ensuring that all research activities contribute meaningfully to the global healthcare landscape. Through its robust clinical trial infrastructure, UMC Utrecht plays a vital role in facilitating the development of new treatments and enhancing patient wellbeing.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Utrecht, , Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported